Orrin Hatch: “I rise today to voice my great concern about FDA's recent announced cutbacks in its cosmetic regulatory program. I…”

“I rise today to voice my great concern about FDA's recent announced cutbacks in its cosmetic regulatory program. I wanted to bring to your attention a matter concerning the funding of the Food and Drug Administration's (FDA) regulatory program for cosmetics. While I am mindful of how difficult appropriations allocation decisions are given the discretionary budgetary caps we enacted last year, I know that you have consistently worked over the years to see that the FDA would have adequate funding for its vital consumer protection mission. It has come to my attention that FDA has recently informed the cosmetic industry of its intent to decrease substantially both the personnel and financial resources devoted toward its cosmetics regulatory program.”